VCYT

NASDAQ 已收盘

Veracyte

25.04 USD
▼-0.53-2.07%
盘后 25.07 +0.12%
2026-11-19
市值
$2.03B
市盈率
16.41
EPS
1.53
股息率
—
52 周区间
21.91 – 60.91
成交量
1.87M
Beta
1.96
目标价
41.60
52W 低 21.9152W 高 60.91
价格走势

公司简介

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its n...